What is the Bridge Biotherapeutics Inc. stock price forecast?

Bridge Biotherapeutics Inc. is currently trading at ₩416. View real-time AI analysis on Alpha Lenz.

What is Bridge Biotherapeutics Inc. insider trading activity?

View the latest insider trading data for Bridge Biotherapeutics Inc. on Alpha Lenz.

What is Bridge Biotherapeutics Inc.'s P/E ratio?

Bridge Biotherapeutics Inc.'s P/E ratio is -0.9.

Bridge Biotherapeutics Inc.

KRX · 288330

₩416-13(-3.03%)Market closed

Ask about Bridge Biotherapeutics Inc.'s future dividend policy...

Alpha Chat Insight

“Bridge Biotherapeutics Inc. trades at a P/E of -0.9 (undervalued) with modest ROE of -86.7%.”

Ask for details →

Company Overview

Bridge Biotherapeutics Inc. is a biotechnology company focused on the discovery and development of novel therapeutics for unmet medical needs. Its primary function is the research and clinical development of new drug candidates, with a particular emphasis on innovative therapies for diseases where treatment options remain limited. The company is known for its work in areas such as fibrosis, inflammation, and oncology, aiming to bring transformative medicines to the market. Bridge Biotherapeutics plays a significant role in the pharmaceutical industry by advancing clinical-stage compounds through partnerships and collaborations with global pharmaceutical companies and research institutions. This company underscores the dynamic and collaborative nature of biotech firms in addressing pressing health challenges worldwide.

CEOAndrew Kim

Websitehttps://bridgebiorx.com

SectorHealthcare

IndustryBiotechnology

Employees35

Company Statistics

FY 2024

Profile

₩44,129,674,368Market Cap

₩2,178,070Revenue

106.08MShares Out

35Employees

Margins

42.15%Gross

-792624.85%EBITDA

-872715.85%Operating

-915166.60%Pre-Tax

-915166.60%Net

Valuation

-0.86P/E

0.65P/B

7773.52EV/Sales

-0.88EV/EBITDA

-0.81P/FCF

Growth (CAGR)

-89.58%Rev 3Yr

-86.98%Rev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-60.24%ROA

-86.75%ROE

-59.67%ROIC

Financial Health

₩5,736,741,530Cash & Cash Equivalents

₩190,846,580Net Debt

21.50%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Bridge Biotherapeutics Inc. trades at a P/E of -0.9 (undervalued) with modest ROE of -86.7%.”

Ask for details →

Frequently Asked Questions

Bridge Biotherapeutics Inc. (ticker: 288330) is a company listed on KRX in the Healthcare sector (Biotechnology). It has approximately 35 employees. Market cap is $44.1B.

The current price is ₩416 with a P/E ratio of -0.86x and P/B of 0.65x.

ROE is -86.75% and operating margin is -872715.85%. Annual revenue is $2M.